A fake inhaler made asthma patients feel better while their lungs showed no change

Key takeaways

• In a 2011 study, a dummy inhaler and fake acupuncture made asthma patients feel nearly as much better as a real inhaler did, but only the real drug improved their breathing tests.
• For symptoms only you can feel, such as pain, your report is the main evidence, and the FDA accepts well-built symptom measures as evidence of whether a treatment works.
• About 4 in 10 U.S. adults with high blood pressure haven’t been told they have it, and the CDC estimates 11 million adults have diabetes that hasn’t been diagnosed.
• Numbers can mislead too: in a large NIH trial, pushing blood sugar down to near-normal levels in high-risk adults led to more deaths, not fewer.
• Track how you feel and what can be measured side by side, with short daily ratings and readings taken the same way each time.

In a study published in 2011, 46 adults with mild to moderate asthma agreed to an unusual experiment. Thirty-nine of them finished it².

Over 12 visits, each person tried four options in random order: albuterol, a common rescue inhaler; a dummy inhaler with no drug in it; fake acupuncture; and no treatment at all¹². At each visit, a breathing test measured how much air they could blow out in one second, a number doctors call FEV1. Patients also rated how much better they felt on a 0-to-10 scale².

The breathing test told one story: albuterol raised FEV1 by about 20%. The dummy inhaler, the fake acupuncture and doing nothing each raised it by about 7%¹.

The patients told another, rating their improvement at 50% after albuterol, 45% after the dummy inhaler and 46% after fake acupuncture. With no treatment, it was 21%¹. Patients couldn’t reliably tell the real drug from the fakes².

Feeling better and getting better are both real, and they often move together. This study, led by Michael Wechsler and Ted Kaptchuk and published in the New England Journal of Medicine, caught them splitting apart¹. Knowing when that can happen, and what to do about it, is one of the most useful health skills you can build.

In asthma, feeling better without breathing better is a risk

The authors drew a careful lesson. Placebo-type relief can matter to patients, they wrote, but it doesn’t show that the airways changed. In asthma care, they argued, objective measures should carry more weight than how a patient feels².

Why would people feel relief their lungs didn’t show? The researchers suggested that people may simply not sense changes in airway function well. They judged it less likely that patients were just telling researchers what they wanted to hear².

The study had clear limits. It was a small pilot that looked only at short-term responses, and the authors said it needed to be repeated². They also noted that emergency visits and quality of life may matter more to patients than a breathing number alone².

Everyday asthma care already builds in this lesson. An asthma action plan uses a peak flow meter, a handheld device that measures how fast you can blow air out. Readings are sorted into zones by how they compare with your personal best³.

In the yellow zone, at 50% to under 80% of your best, lung function may already be reduced even when you feel no symptoms. In a severe attack, wheezing may fade, and that’s a more dangerous sign, not a better one³.

For some problems, how you feel is the main result

None of this means your experience is unreliable. For many conditions, it’s the best evidence there is.

The Food and Drug Administration (FDA) set out how drug companies should measure patient experience in a 2009 guidance. It defines a patient-reported outcome as a report that comes straight from the patient, with no one else interpreting it⁴. The FDA advises using this kind of measure for things the patient knows best, and pain is among its examples⁴.

In late 2025, the FDA finalized newer guidance on choosing these measures for drug trials. The document is dated October 2025, and the agency announced it in November⁵¹⁴. It covers four kinds: reports from patients, from other observers and from clinicians, plus performance tests in which a person completes a set task¹⁴.

For chronic pain, migraine, nausea, fatigue and irritable bowel syndrome, the symptom is the problem. If you feel better, you are better in the way that counts most.

Researchers have even worked out how much change people notice. A 2001 analysis of 10 pain trials with 2,724 people found that a drop of about 2 points on a 0-to-10 pain scale, or about 30%, matched the point where people called themselves “much improved”⁶. A companion article on what meaningful clinical benefits look like explains this idea, called the minimal clinically important difference, in more depth.

Why the two signals drift apart

When how you feel and what can be measured disagree, a few forces are usually at work.

• Expectation and care. A Cochrane review of placebo trials found that, on rating scales, placebos affected what patients reported about twice as much as what observers recorded. Lab results didn’t budge⁷. The companion article on placebo and nocebo effects covers this in depth.
• What the body doesn’t announce. Some changes, such as narrowing airways or rising blood pressure, can’t be reliably felt²³¹⁰.
• Memory and mood. The FDA guidance warns that people’s answers about past weeks are colored by how they feel when they answer. It favors short recall periods or questions about how people feel right now, and it suggests diaries when people would otherwise have to remember a long stretch⁴.
• Measurement noise. Readings bounce around. The CDC advises taking at least two blood pressure readings, a minute or two apart, at the same time each day⁸.

Neither signal is the “true” one. Each catches things the other misses.

Some serious conditions make no noise

For certain conditions, feeling fine tells you very little.

The CDC says high blood pressure usually has no warning signs or symptoms, and the only way to know you have it is to measure it¹⁰. Left unmanaged, it can lead to heart attack and stroke¹⁰.

National survey data from August 2021 to August 2023 show the size of the gap. Nearly half of U.S. adults, 47.7%, had high blood pressure, defined as 130/80 or higher or taking medicine for it⁹. Only 59.2% of them had been told by a health professional that they had it⁹.

Among adults ages 18 to 39 with high blood pressure, just 27.2% knew⁹. Only about 1 in 5 adults with high blood pressure had it under control⁹.

Diabetes follows a similar pattern. The CDC says type 2 diabetes symptoms often take several years to develop, and some people don’t notice any at all¹².

On a statistics page updated in September 2026, the agency estimated that 11.0 million U.S. adults have diabetes that hasn’t been diagnosed. That’s 27.6% of all adults with diabetes¹¹.

“Listen to your body” is a core natural-health value, and a good one. Measuring is another way to listen: it picks up signals your body doesn’t put into words.

If you’re using food, movement, sleep or herbs to manage blood pressure or blood sugar, the numbers are how you’ll know your plan is working. They also give you something concrete to show a clinician who doubts it.

A better number doesn’t always mean a better life

Measurements can mislead too. Doctors often track a stand-in number, called a surrogate marker, because it’s quicker to measure than heart attacks or deaths. That shortcut is useful, but it can backfire.

The ACCORD trial, overseen by the National Heart, Lung, and Blood Institute, enrolled 10,251 adults with type 2 diabetes who had heart disease or at least two risk factors for it¹³. One group aimed for an A1C, a measure of average blood sugar, below 6%, a near-normal level. The other aimed for 7% to 7.9%¹³.

The tighter target did bring blood sugar down. But after an average of 3.5 years, 257 people in the intensive group had died, compared with 203 in the standard group¹³. The intensive approach also didn’t significantly cut heart attacks and strokes¹³.

The institute stopped the intensive strategy early, in February 2008¹³. The researchers cautioned that the results might not apply to people at lower risk or newly diagnosed¹³.

The lesson isn’t that numbers don’t matter. It’s that the outcomes that count most are how long you live, how well you function and how you feel. A number is valuable when it predicts those outcomes. A companion article on wearables, “Your wearable’s best number is your own normal, not the average,” applies the same thinking to smartwatch data.

Which signal to lean on

Use this table as a starting point for a conversation with your clinician, not as a rule.

Situation	What your experience tells you	What measurements add	Lean on
Chronic pain, migraine, nausea, IBS	The main outcome4	Mostly ruling out other causes	Your experience, rated the same way each day
Asthma	Early warning, but it can lag or mislead2	Peak flow can show narrowing you don’t feel3	Both, using your action plan
High blood pressure	Usually nothing10	The only way to know10	Measurements
Type 2 diabetes	Often nothing for years12	Blood tests reveal it	Measurements, plus how you feel on treatment
Mood, fatigue, sleep quality	The main outcome	Questionnaires turn feelings into scores you can compare	Your experience, scored consistently
A lab number that changed with treatment	Whether you feel and function better	The number may or may not predict real outcomes13	Both; ask what the number predicts

A “track both” routine you can start this week

This routine pulls together the FDA’s advice on reporting symptoms and the CDC’s advice on home blood pressure. Adjust it with your clinician for your condition.

1. Choose what to track. Pick one or two symptoms that matter most to you and one measurement that fits your condition, such as blood pressure or peak flow.
2. Rate symptoms daily, at the same time. Use a 0-to-10 scale and rate today only, not the past week. Short recall is more reliable⁴.
3. Measure the standard way. For blood pressure, skip food, drinks, caffeine, smoking and exercise for 30 minutes first, and empty your bladder. Sit for 5 minutes with your back supported, feet flat and arm resting at chest height. Put the cuff on bare skin and don’t talk. Take at least two readings a minute or two apart, and write them all down⁸.
4. Note the context. Jot down sleep, stress, illness, missed doses and anything new you started.
5. Get a baseline first. Track for a couple of weeks before you change anything, so you know your normal ups and downs.
6. Change one thing at a time. If you start an herb and a new diet in the same week, you won’t know which did what.
7. Decide in advance what counts. For pain, about 2 points or 30% is a change most people notice⁶. For a measurement, ask your clinician what change would matter.
8. Review the split. Every few weeks, compare the two columns and bring the log to appointments.

If you feel better but your numbers haven’t moved, keep the habit that helps, but don’t drop treatment that controls the number. If your numbers improved but you feel worse, tell your clinician. Side effects and dose are worth discussing, and how you feel is part of the result.

What the evidence shows

Claim	Evidence rating	What it rests on
Sham treatments can make asthma patients feel better without improving lung function	Promising but early	One small pilot trial of short-term responses12
Patient reports are valid evidence for symptoms only patients can feel	Strong evidence	FDA accepts them in drug trials; large pain-trial analysis46
High blood pressure and type 2 diabetes often cause no symptoms	Strong evidence	National survey and CDC data9101112
Improving a lab number always improves health	Evidence says no	ACCORD trial: tighter blood sugar, more deaths13
Feeling fine means a silent condition is under control	Evidence says no	Only about 1 in 5 adults with high blood pressure have it controlled910

Questions readers ask

The bottom line

How you feel is real evidence, and for pain, nausea, fatigue and mood it’s often the most important evidence there is. Measurements are real evidence too, and for silent conditions such as high blood pressure and early diabetes they’re often the only warning you’ll get.

Often the two agree. When they split, as they did in the asthma study, neither should win by default. Track both, change one thing at a time, and bring the whole picture to someone who can help you read it.

Related reading

• Placebos ease how you feel but rarely change what doctors measure
• Your wearable’s best number is your own normal, not the average
• Why one flagged lab number is not a diagnosis
• What a medical test can and cannot tell you
• Even Lourdes tests its healings, and you can weigh your own experience the same way

Sources

1. Wechsler ME, Kelley JM, Boyd IOE, Dutile S, Marigowda G, Kirsch I, Israel E, Kaptchuk TJ. “Active Albuterol or Placebo, Sham Acupuncture, or No Intervention in Asthma.” New England Journal of Medicine, 2011;365(2):119-126 (Harvard DASH record). doi.org
2. Wechsler ME, Kelley JM, Boyd IOE, et al. “Active Albuterol or Placebo, Sham Acupuncture, or No Intervention in Asthma.” New England Journal of Medicine, 2011 (full text). tedkaptchuk.com
3. Michigan Medicine Health Library (Healthwise). “Asthma Action Plan.” University of Michigan Health, 2023. uofmhealth.org
4. U.S. Food and Drug Administration. “Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims.” Guidance for Industry, December 2009. hhs.gov
5. Eglovitch JS. “FDA Finalizes Guidance on Patient-Focused Drug Development.” Regulatory Affairs Professionals Society, November 18, 2025. raps.org
6. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM. “Clinical Importance of Changes in Chronic Pain Intensity Measured on an 11-Point Numerical Pain Rating Scale.” Pain, 2001;94(2):149-158. pubmed.ncbi.nlm.nih.gov
7. Hróbjartsson A, Gøtzsche PC. “Placebo Interventions for All Clinical Conditions.” Cochrane Database of Systematic Reviews, 2010, Issue 1, CD003974. cochrane.org
8. Centers for Disease Control and Prevention. “Measure Your Blood Pressure.” CDC, reviewed 2024. cdc.gov
9. Fryar CD, Kit B, Carroll MD, Afful J. “Hypertension Prevalence, Awareness, Treatment, and Control Among Adults Age 18 and Older: United States, August 2021–August 2023.” NCHS Data Brief No. 511, CDC, 2024. cdc.gov
10. Centers for Disease Control and Prevention. “About High Blood Pressure.” CDC, reviewed January 2026. cdc.gov
11. Centers for Disease Control and Prevention. “National Diabetes Statistics Report.” CDC, updated September 16, 2026. cdc.gov
12. Centers for Disease Control and Prevention. “Diabetes Symptoms.” CDC, reviewed 2024. cdc.gov
13. National Heart, Lung, and Blood Institute. “Targeting Blood Sugar to Near-Normal Levels Increases Risk of Death in Persons With Diabetes at High Risk, ACCORD Trial Shows.” NIH news release via ScienceDaily, June 6, 2008. sciencedaily.com
14. U.S. Food and Drug Administration. “Patient-Focused Drug Development: Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments.” Guidance for Industry, October 2025. fda.gov